Pure Global

Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography - Trial NCT05130775

Access comprehensive clinical trial information for NCT05130775 through Pure Global AI's free database. This phase not specified trial is sponsored by Tufts Medical Center and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05130775
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05130775
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography

Study Focus

Tricuspid Regurgitation

Transesophageal echocardiograpgy

Observational

other

Sponsor & Location

Tufts Medical Center

Boston, United States of America

Timeline & Enrollment

N/A

Aug 22, 2022

Jul 15, 2023

60 participants

Primary Outcome

Tricuspid regurgitation volume

Summary

This study is a prospective observational chart review. The aim of the study is to evaluate
 tricuspid regurgitation volume using 3D volumetric assessment as an accurate method for
 tricuspid regurgitation severity in comparison to VCA.

ICD-10 Classifications

Tricuspid stenosis
Tricuspid stenosis with insufficiency
Nonrheumatic tricuspid (valve) stenosis
Tricuspid insufficiency
Nonrheumatic tricuspid (valve) stenosis with insufficiency

Data Source

ClinicalTrials.gov

NCT05130775

Non-Device Trial